Diagnosis of Oral Cancer With Deep Learning. A Comparative Test Accuracy Systematic Review
Oral Diseases,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 31, 2025
ABSTRACT
Objective
To
directly
compare
the
diagnostic
accuracy
of
deep
learning
models
with
human
experts
and
other
methods
used
for
clinical
detection
oral
cancer.
Methods
Comparative
studies
involving
patients
photographic
images
mucosal
lesions
(cancer
or
non‐cancer)
were
included.
Only
using
eligible.
Medline,
EMBASE,
Scopus,
Google
Scholar,
ClinicalTrials.gov
searched
until
September
2024.
QUADAS‐C
assessed
risk
bias.
A
Bayesian
meta‐analysis
compared
test
accuracy.
Results
Eight
included,
none
which
had
a
low
Three
versus
experts.
The
difference
in
sensitivity
favored
by
0.024
(95%
CI:
−0.093,
0.206),
while
specificity
−0.041
−0.218,
0.038).
Two
postgraduate
medical
students.
differences
0.108
−0.038,
0.324)
0.010
−0.119,
0.111),
respectively.
Both
comparisons
provided
low‐level
evidence.
Conclusions
Deep
showed
comparable
to
These
outperformed
students
terms
sensitivity.
Prospective
trials
are
needed
evaluate
real‐world
performance
models.
Language: Английский
Surgical extraction with photobiomodulation as an adjunctive modality in patients at-risk for medication-related osteonecrosis of the jaw: retrospective study
BMC Oral Health,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 24, 2025
The
study
aims
to
retrospectively
assess
and
share
the
experience
of
use
photobiomodulation
(PBM)
as
an
adjunctive
surgical
extraction
in
patients
at-risk
for
medication-related
osteonecrosis
jaw
(MRONJ)
due
a
treatment
history
with
bone-modifying
agents.
department
database
medical
records
were
examined
period
between
2016
2023.
inclusion
criteria
were;
MRONJ
current
or
previous
agents,
without
antiangiogenic
agents
administration,
who
underwent
single
multiple
dental
extractions,
subjected
PBM
preventive
protocol,
diagnosis
development.
protocol
consisted
four
sessions,
two
sessions
before
intervention
after
intervention.
parameters
(per
session)
total
power
0.6
W,
time
15
min,
frequency
30
kHz,
energy
577.4
J.
A
62
(58
females
4
males)
fulfilled
mean
age
67.5
years.
Complete
healing
development
was
shown
50
(80.65%)
patients,
12
(19.35%)
patients.
statistical
analysis
revealed
higher
risk
administration
zoledronic
acid
(p
=
0.029)
undergoing
corticosteroid
therapy
0.039).
While
lower
observed
thyroid
pathology
0.055).
majority
included
showed
complete
modality.
Corticosteroid
systemic
factor
drug-related
show
significant
associations
MRONJ.
Language: Английский